Breaking News
September 21, 2018 - NIH and FDA call for eliminating involvement of RAC in human gene therapy experiments
September 21, 2018 - New system uses algorithm to convert 2D videos into 3D printed ‘motion sculptures’
September 21, 2018 - Sea squirt model reveals key molecules in dopaminergic neuron differentiation
September 21, 2018 - Effective management of neonatal abstinence syndrome requires coordinated ‘cascade of care’
September 21, 2018 - Refugees seek care for wounds of war
September 21, 2018 - Under the sea, in an octopus’ garden on ecstacy
September 21, 2018 - Eating foods with low nutritional quality ratings linked to cancer risk in large European cohort
September 21, 2018 - Giving kids honest information about water consumption may help them make healthy choices
September 21, 2018 - Horwitz Prize Awarded for Work on Hormones
September 21, 2018 - CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients
September 21, 2018 - Scientists discover new molecules that work together to remove unwanted DNA
September 21, 2018 - Dr. Fenella France to deliver 2019 Plenary Lecture
September 21, 2018 - New research finds that MHC-II molecules have more influence on tumors than MHC-I
September 21, 2018 - Researchers study effects of cardiac cycle in simple learning task
September 21, 2018 - FDA takes new steps to address opioid crisis by approving Opioid Analgesic Risk Evaluation and Mitigation Strategy
September 21, 2018 - Positive Barhemsys Phase 3 Treatment Data Published in Anesthesia & Analgesia
September 21, 2018 - Celiac Disease Screening: MedlinePlus Lab Test Information
September 21, 2018 - Autism linked to egg cells’ difficulty creating large proteins
September 21, 2018 - Tweaking nuclear pores could provide new avenue to battle against cancer
September 21, 2018 - Experts warn health care providers to slow down in allowing smart pill in patient care settings
September 21, 2018 - MoreGrasp reports breakthrough development of grasp neuroprosthetics activated by thought control
September 21, 2018 - Study reveals new way to target HER2-negative metastatic breast cancer
September 21, 2018 - CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL
September 21, 2018 - Study offers solid link between visceral organs and brain’s reward, motivation system
September 21, 2018 - First U.S. patient treated with innovative gene therapy at Bascom Palmer Eye Institute
September 21, 2018 - Choroidal Detachment – The American Society of Retina Specialists
September 21, 2018 - Discovery of a key protein involved in the development of autism
September 21, 2018 - Air pollution appears to be linked to increased risk of developing dementia
September 21, 2018 - Henry Ford Health System receives $600k grant to study genetic makeup of gliomas
September 21, 2018 - Arthritis common in individuals with varying degrees of depression, finds study
September 21, 2018 - Scientist intends to fight pathogenic bacteria with viruses
September 21, 2018 - New research suggests link between PFAS chemicals and hyperthyroidism in pet cats
September 21, 2018 - Multi-year study data shows impact of new soft contact lens to slow myopia progression in children
September 21, 2018 - Neuroscientists identify circuit for brain’s statistical inference about motion
September 21, 2018 - MILabs’ VECTor6 system wins Commercial Innovation Award at WMIC 2018
September 21, 2018 - Scientists find wild African monkeys infected with bacterium that causes syphilis, yaws in humans
September 21, 2018 - 2006 to 2015 Saw Increase in Severe Maternal Morbidity
September 21, 2018 - Similar changes in the brains of patients with ADHD and emotional instability
September 21, 2018 - Cobalt mining in DR Congo takes a high toll on both creuseurs and environment
September 21, 2018 - Eating fatty fish during pregnancy may boost unborn child’s brain development
September 21, 2018 - Study reveals promising new drug candidate to treat acute renal failure
September 21, 2018 - Neural signal that urges to eat overpowers the one that says to stop
September 21, 2018 - Scientists achieve breakthrough in accelerated diagnosis of multi-resistant hospital pathogens
September 21, 2018 - Researchers simulate how different breast tissues respond to heat from MRIs
September 21, 2018 - Despite red flags at surgery centers, overseers award gold seals
September 21, 2018 - Zapping Airway Nerves May Help COPD Patients Breathe
September 21, 2018 - Researchers find answers as to why some people are at risk of gout
September 21, 2018 - Stars of Stanford Medicine: Genetic counseling and compassion
September 21, 2018 - Researchers use reinforcement learning to train gliders to soar like birds
September 21, 2018 - New federally-funded research project could lead to treatments that extend human lifespan
September 21, 2018 - Health insurance ads have shifted over time due to health plans offered via ACA
September 21, 2018 - Use of transcranial electrical stimulation to bolster creativity has far-reaching implications
September 21, 2018 - Scientists find way to boost efficacy of powerful antimalarial drug with anti-cancer medicines
September 21, 2018 - Weighing the risks and benefits of drug tapering—two patients, two perspectives
September 21, 2018 - The “exposome” revealed: a barrage of bacteria, chemicals, microscopic animals and more
September 21, 2018 - Top three immune boosting recommendations to ward off freshers’ flu
September 21, 2018 - Young children’s oral microbiota could serve as early indicator for obesity
September 21, 2018 - Older individuals with multiple sclerosis report higher quality of life than younger counterparts
September 21, 2018 - LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines
September 21, 2018 - AbbVie Presents Upadacitinib Longer-Term (32-Week) and Patient-Reported Outcomes Data from Phase 2b Atopic Dermatitis Study at 27th European Academy of Dermatology and Venereology (EADV) Congress
September 21, 2018 - Alzheimer’s drug may stop disease if used before symptoms develop
September 21, 2018 - Human skeletal stem cell can generate cartilage, bone
September 21, 2018 - UK and European research collaborations receive vote of confidence by three major cancer charities
September 21, 2018 - Microbiota in the intestines and cell stress cause colon cancer
September 20, 2018 - Arizona EMTs have 39% higher risk for suicide than general public
September 20, 2018 - Driving and older adults: MedlinePlus Medical Encyclopedia
September 20, 2018 - Brain region for stress control is enlarged in people with depression, finds study
September 20, 2018 - Researchers test autobiographical memory for early Alzheimer’s detection
September 20, 2018 - Organizations join forces to help teens with severe mental health challenges | News Center
September 20, 2018 - Neurons in the human brain can encode numerical information
September 20, 2018 - Potential drugs to treat neurodegenerative diseases garner $3 million grant
September 20, 2018 - Processing speed important to higher order cognitive function in multiple sclerosis patients
September 20, 2018 - Helping a patient survive a hurricane
September 20, 2018 - Tafamidis Treats Transthyretin Amyloid Cardiomyopathy
September 20, 2018 - Low academic achievement can lead to drug abuse decades later, research finds
September 20, 2018 - Study identifies stem cell that gives rise to new bone, cartilage in humans | News Center
September 20, 2018 - Celltrion and Emory University sign ‘Incubation’ agreement to develop new drug candidates for atherosclerosis
September 20, 2018 - TGen and PNOC take part in launch of NIH-supported Kids First Data Resource Portal
September 20, 2018 - Could Household Cleaners Make Your Kid Fat?
September 20, 2018 - Addiction nonprofit makes searching for services simple
The Digital Health Platform That’s Tackling Chronic Health Conditions

The Digital Health Platform That’s Tackling Chronic Health Conditions

image_pdfDownload PDFimage_print

An interview with Simon Pickup, UK Managing Director of Liva Healthcare, about the Liva digital health platform and how it can be used to help patients change their lives for the better.

Heart disease and diabetes are amongst the biggest killers in the world today. How can lifestyle apps such as those offered by Liva Healthcare help to reduce the prevalence of these diseases and save lives?

The Liva digital health platform is all about changing lifestyles for the better. We help patients improve their lifestyle through a process called behavioral change therapy.

Lifestyle change, woman starting to runImage Credit: LMproduction / Shutterstock

Patients are given individual goals that range from eating smaller portion sizes, increasing the amount of exercise they do, even improving sleep patterns, all of which have been linked to chronic disease.

How does the Liva app work?

The program is a combination of a professional health coach and our state-of-the-art digital platform. The patient initially meets up with a health coach who comes up with an individualized health plan. Everybody has a different plan depending on their needs, and the condition they are suffering with.

During the hour, incremental step changes in the form of goals are put into place. The patient then uses the platform to manage their health and meet these goals. The coach can see everything the participant is doing through the platform and is able to help the patient meet their goals.

The platform isn’t just for one chronic condition. It is suitable for all chronic conditions. For example, patients with Type 2 diabetes often have lots of co-morbidities that need to be taken into consideration before recommending a health plan.

The NHS program for diabetes prevention is currently 12 months. We have set-interval coaching throughout this period and at any point in time, the coach can monitor the performance of all the patients that they are managing, which, in turn, helps drive efficiency.

Liva app

What types of lifestyle changes does the app recommend? Why is it so effective at helping people to lose weight?

There are a number of goals that are available on the platform, and we’re releasing new ones all the time, depending on the condition that the patient is suffering with.

There are around 20 goals at the moment, and as I said earlier, it’s about setting individual goals for that particular patient. Not everybody follows the same plan, and the focus of each plan is different.

Once they’ve achieved or attained that goal, we either switch that goal off and turn another one on or increase their goal settings.

To give you an example, our clinical studies have shown that not only can patients lose 7.4kg within the first four months but they are actually able to sustain this weight loss 20 months later. Which is about 7.2% of their BMI. We have published results like these in several reputable journals.

It takes about three months in general to change a lifestyle, but it can take up to 18 months to keep that lifestyle. This isn’t a fad diet. It’s about momentum. Slow, incremental changes that help patients change their lifestyle permanently.

It’s about getting people to slowly, incrementally change the way they live, which means that they will stick to it. It becomes a permanent lifestyle change.

Do you think that every patient in the UK should use a lifestyle app? If yes, what age would you recommend that people start using them?

Interestingly, my ten-year-old daughter has a lifestyle app. I think it’s more of a craze than actually doing anything with it. But you know what? It’s been proven that children as young as 5 could do with a change of their lifestyle, which is a really scary statistic.

For us, it’s about educating the adults to change their lifestyles and then hopefully that knowledge will be passed on to the next generation. There are lots of school initiatives with famous chefs to improve the way our children are eating in school, and that helps too.

How can healthcare apps such as Liva help to reduce the economic pressures faced by today’s NHS?

We currently offer our program as a pilot in two regions for the NHS; in Humber, Coast and Vale and North East London. We’d like to extend our service to more regions, for example, to CCG’s in different regions that manage diabetics, but also to CCGs who manage other chronic diseases, for example, respiratory diseases.

We’re also looking to partner with pharmaceutical companies to improve outcomes for patients using one of their products. We’re just about to start a pilot with one particular pharmaceutical company in two regions globally.

Liva has been proven to reduce the costs faced by the NHS, simply because we are able to improve people’s lifestyles. For example, patients who successfully use the platform are able to reverse their Type 2 diabetes, and others are no longer at risk of developing diabetes. This allows us to reduce the cost burden of medication on the NHS.

The cost for a Type 2 diabetic with severe complications is around £35,000 a year. On average, we can prove that per patient we can save around €2,000 in societal cost savings.

This doesn’t seem like a lot of money, but if you multiply it by a huge cohort of patients, it’s huge savings.

Where can readers find more information?

For more information, head to the Liva Healthcare website.

About Liva Healthcare

Founded in 2014, Liva Healthcare is an innovative digital health coaching platform for scalable lifestyle and disease management.  

Winner of ‘Health IT Firm of the Year’ at the HealthInvestor Awards 2018 and ‘Healthtech Innovators of the Year – Europe at the Global Health & Pharma Awards 2018, Liva Healthcare is used by public health care, private insurance and pharma companies including NHS England, AXA PPP Healthcare and Copenhagen Municipality.  

Liva Healthcare’s platform facilitates ongoing personalised health coaching through an intuitive platform, building strong bond between coach, GP and patient. Its focus lies on tackling chronic illnesses, such as Type 2 diabetes, obesity and heart disease, by driving behaviour change.   

Currently being used in Denmark, UK and Sweden, the platform is multilingual across several languages. It has proven to work efficiently across all socio-economic backgrounds and is capable of engaging groups normally hard to reach.

It is based upon nine to 18 months of continuous patient engagement to make new habits and behaviours stick. One coach can manage 500 patients per year simultaneously without the loss of patient outcomes.  

Implementation time from get-go is normally within weeks and the platform is available as a white-label SaaS platform, or as a turn-key solution, dependent on client specifications.  

Liva Healthcare has offices in Copenhagen, Denmark and London, UK.  

Liva Healthcare logo

Tagged with:

About author

Related Articles